Veeva Systems Return on Tangible Equity 2012-2025 | VEEV
Current and historical return on tangible equity values for Veeva Systems (VEEV) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Veeva Systems Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-04-30 | $0.78B | $5.73B | 15.03% |
| 2025-01-31 | $0.72B | $5.35B | 14.71% |
| 2024-10-31 | $0.67B | $5.01B | 14.61% |
| 2024-07-31 | $0.62B | $4.69B | 14.39% |
| 2024-04-30 | $0.56B | $4.39B | 13.86% |
| 2024-01-31 | $0.53B | $4.14B | 13.95% |
| 2023-10-31 | $0.57B | $3.87B | 16.08% |
| 2023-07-31 | $0.54B | $3.64B | 16.46% |
| 2023-04-30 | $0.52B | $3.43B | 17.02% |
| 2023-01-31 | $0.49B | $3.19B | 17.23% |
| 2022-10-31 | $0.40B | $2.89B | 15.08% |
| 2022-07-31 | $0.39B | $2.71B | 16.01% |
| 2022-04-30 | $0.41B | $2.53B | 17.90% |
| 2022-01-31 | $0.43B | $2.37B | 19.97% |
| 2021-10-31 | $0.43B | $2.23B | 21.92% |
| 2021-07-31 | $0.43B | $2.08B | 23.47% |
| 2021-04-30 | $0.41B | $1.90B | 25.00% |
| 2021-01-31 | $0.38B | $1.72B | 25.86% |
| 2020-10-31 | $0.34B | $1.55B | 26.11% |
| 2020-07-31 | $0.33B | $1.39B | 25.49% |
| 2020-04-30 | $0.31B | $1.23B | 24.65% |
| 2020-01-31 | $0.30B | $1.09B | 23.63% |
| 2019-10-31 | $0.31B | $1.44B | 23.90% |
| 2019-07-31 | $0.29B | $1.33B | 24.55% |
| 2019-04-30 | $0.26B | $1.22B | 24.13% |
| 2019-01-31 | $0.23B | $1.12B | 23.43% |
| 2018-10-31 | $0.20B | $1.02B | 22.29% |
| 2018-07-31 | $0.17B | $0.93B | 20.96% |
| 2018-04-30 | $0.16B | $0.85B | 21.54% |
| 2018-01-31 | $0.15B | $0.78B | 22.69% |
| 2017-10-31 | $0.14B | $0.69B | 23.32% |
| 2017-07-31 | $0.13B | $0.64B | 23.28% |
| 2017-04-30 | $0.10B | $0.58B | 20.51% |
| 2017-01-31 | $0.08B | $0.52B | 17.31% |
| 2016-10-31 | $0.07B | $0.47B | 16.04% |
| 2016-07-31 | $0.05B | $0.43B | 14.33% |
| 2016-04-30 | $0.05B | $0.39B | 14.25% |
| 2016-01-31 | $0.05B | $0.36B | 14.05% |
| 2015-10-31 | $0.05B | $0.33B | 12.47% |
| 2015-07-31 | $0.05B | $0.44B | 12.15% |
| 2015-04-30 | $0.05B | $0.41B | 12.07% |
| 2015-01-31 | $0.04B | $0.40B | 11.16% |
| 2014-10-31 | $0.02B | $0.37B | 7.35% |
| 2014-07-31 | $0.02B | $0.35B | 5.36% |
| 2014-04-30 | $0.01B | $0.32B | 5.67% |
| 2014-01-31 | $0.01B | $0.27B | 7.58% |
| 2013-07-31 | $0.02B | 0.00% | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $45.084B | $2.747B |
| Veeva Systems Inc. offers cloud-based software applications and data solutions for the life sciences industry. The company's product portfolio includes Veeva CRM (customer relationship management), Veeva Vault (content and information management), Veeva Network (customer master and product data management) and Veeva data services (Veeva OpenData and Veeva KOL data). | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Doximity (DOCS) | United States | $11.307B | 52.35 |
| Hims & Hers Health (HIMS) | United States | $10.719B | 111.37 |
| Tempus AI (TEM) | United States | $9.847B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.340B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.842B | 60.03 |
| Hinge Health (HNGE) | United States | $3.717B | 0.00 |
| Privia Health (PRVA) | United States | $2.496B | 170.58 |
| Enovis (ENOV) | United States | $1.944B | 10.84 |
| Phreesia (PHR) | United States | $1.590B | 0.00 |
| 10x Genomics (TXG) | United States | $1.576B | 0.00 |
| Schrodinger (SDGR) | United States | $1.542B | 0.00 |
| Azenta (AZTA) | United States | $1.532B | 71.21 |
| Clover Health Investments (CLOV) | United States | $1.486B | 0.00 |
| Omnicell (OMCL) | United States | $1.344B | 23.71 |
| Evolent Health (EVH) | United States | $1.313B | 111.80 |
| Claritev (CTEV) | United States | $0.761B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.587B | 0.00 |
| Veradigm (MDRX) | United States | $0.547B | 0.00 |
| Standard BioTools (LAB) | United States | $0.501B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.448B | 0.00 |
| Talkspace (TALK) | United States | $0.442B | 132.00 |
| Outset Medical (OM) | United States | $0.344B | 0.00 |
| TruBridge (TBRG) | United States | $0.331B | 735.33 |
| Health Catalyst (HCAT) | United States | $0.271B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.257B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.161B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.150B | 0.00 |
| American Well (AMWL) | United States | $0.131B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.123B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.103B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 3.84 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.082B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.068B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| HeartBeam (BEAT) | United States | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Precipio (PRPO) | United States | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |